- |||||||||| latanoprost / Generic mfg.
Biomarker, Trial primary completion date: Glaucoma Biomarkers (clinicaltrials.gov) - Jan 22, 2015 P=N/A, N=150, Recruiting, Recruiting --> Active, not recruiting Trial primary completion date: Jan 2015 --> Dec 2015
- |||||||||| ketorolac / Generic mfg., prednisolone acetate ophthalmic suspension / Generic mfg.
Trial suspension, Trial primary completion date: SALT: Steroids After Laser Trabeculoplasty for Glaucoma (clinicaltrials.gov) - Dec 30, 2014 P4, N=300, Suspended, Recruiting --> Completed | N=126 --> 169 | Trial primary completion date: Dec 2014 --> Sep 2014 Recruiting --> Suspended | Trial primary completion date: Sep 2014 --> Sep 2015
- |||||||||| Helios ocular insert (bimatoprost sustained release insert) / AbbVie
Trial completion, Enrollment change, Trial primary completion date: A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension (clinicaltrials.gov) - Dec 19, 2014 P1, N=14, Completed, Active, not recruiting --> Completed Recruiting --> Completed | N=20 --> 14 | Trial primary completion date: Mar 2014 --> Jun 2014
- |||||||||| Trial primary completion date: SOLX Gold Shunt for Refractory Glaucoma (clinicaltrials.gov) - Dec 17, 2014
P3, N=60, Active, not recruiting, Recruiting --> Completed | N=20 --> 14 | Trial primary completion date: Mar 2014 --> Jun 2014 Trial primary completion date: Sep 2014 --> Dec 2015
- |||||||||| Trial completion, Trial primary completion date: Neurovascular Coupling in Eyes of Glaucoma Patients (clinicaltrials.gov) - Dec 17, 2014
P=N/A, N=100, Completed, Trial primary completion date: Sep 2014 --> Dec 2015 Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2014
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Safety Study of Latanoprost Slow Release Insert (clinicaltrials.gov) - Dec 9, 2014
P1, N=12, Terminated, Active, not recruiting --> Completed N=15 --> 12 | Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Jun 2014; Study terminated early due to manufacturer not replenishing study site supply of inserts, despite repeated requests for more inserts.
- |||||||||| Phase classification: Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension (clinicaltrials.gov) - Dec 9, 2014
P4, N=600, Enrolling by invitation, N=15 --> 12 | Recruiting --> Terminated | Trial primary completion date: Sep 2014 --> Jun 2014; Study terminated early due to manufacturer not replenishing study site supply of inserts, despite repeated requests for more inserts. Phase classification: P=N/A --> P4
- |||||||||| Trial primary completion date: Novel Glaucoma Diagnostics (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=500, Recruiting, N=50 --> 12 | Recruiting --> Terminated | Trial primary completion date: Nov 2012 --> Feb 2012; short of study staff Trial primary completion date: May 2012 --> May 2017
- |||||||||| timolol maleate ophthalmic solution / Generic mfg., travoprost ophthalmic / Generic mfg.
Trial initiation date: Efficacy of Changing to DuoTrav (clinicaltrials.gov) - Dec 5, 2014 P4, N=37, Terminated, Trial primary completion date: May 2012 --> May 2017 Initiation date: Oct 2012 --> Jun 2012
|